NEW YORK (GenomeWeb News) – Everist Genomics today said that it will open a lab within Johnson & Johnson's Janssen Labs innovation center in San Diego.

The Ann Arbor, Mich.-based personalized medicine technologies firm said that it is one of only 15 firms that have been selected to date by J&J to set up a lab at the innovation center, which was launched in January 2012. It intends to open the lab in the third quarter of this year, enabling the firm to realize cost efficiencies from sharing resources with other firms that set up labs at Janssen Labs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.